tiprankstipranks

Julie Smith Insider Profile

4 Followers
Julie Smith, President & CEO, Director at Raptor Pharmaceutical Corp., holds 15.46K shares in Exelixis (Ticker: EXEL), holds 37.95K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP), holds ― shares in Audentes Therapeutics (Ticker: ~BOLD).
tipranks
Julie Smith

Julie Smith
Raptor Pharmaceutical Corp. (RPTP)
President & CEO, Director

Ranked #67,155 out of 98,042 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-21.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$349K
100.00%
0.00%
A breakdown of Julie Smith's holdings

Insider Roles

Exelixis
(EXEL)
Director
Stoke Therapeutics
(STOK)
Director
Roles that Julie Smith holds in companies

Most Profitable Insider Trade

Stock:
Exelixis
(EXEL)
Rating:Informative Sell
Date:May 23, 2024 - Today
Return:-10.70%
The most profitable trade made by Julie Smith

Julie Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RPTP
Raptor Pharmaceutical Corp.
Feb 11, 2016
Uninformative Buy
$341.55K
Exelixis
Jun 04, 2024
Director
Uninformative Buy
$349.40K
~BOLD
Audentes Therapeutics
Stoke Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Julie Smith's performance on stock

Julie Smith insider profile FAQ

What is the percentage of profitable transactions made by Julie Smith?
The percentage of profitable transactions made by Julie Smith is 0%.
    What is the average return per transaction made by Julie Smith?
    The average return per transaction made by Julie Smith is -21.80%.
      What stocks does Julie Smith hold?
      Julie Smith holds: RPTP, EXEL, ~BOLD, STOK stocks.
        What was Julie Smith’s latest transaction?
        Julie Smith latest transaction was an Uninformative Buy of ―.
          What was Julie Smith's most profitable transaction?
          Julie Smith’s most profitable transaction was an Informative Sell of EXEL stock on May 23, 2024. The return on the trade was -10.70%.
            What is Julie Smith's role in Raptor Pharmaceutical Corp.?
            Julie Smith's role in Raptor Pharmaceutical Corp. is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.